Drug Type Small molecule drug |
Synonyms KRLS 017, KRLS-017, KRLS017 + [2] |
Target |
Mechanism CDK7 inhibitors(Cyclin-dependent kinase 7 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Preclinical | JP | 22 Mar 2024 | |
Advanced Malignant Solid Neoplasm | Preclinical | - | 22 Mar 2024 | |
Breast Cancer | Preclinical | US | 01 Mar 2023 | |
Breast Cancer | Preclinical | JP | 01 Mar 2023 | |
Colonic Cancer | Preclinical | US | 01 Mar 2023 | |
Colonic Cancer | Preclinical | JP | 01 Mar 2023 | |
Malignant Pleural Mesothelioma | Preclinical | US | 01 Mar 2023 | |
Malignant Pleural Mesothelioma | Preclinical | JP | 01 Mar 2023 | |
Non-Small Cell Lung Cancer | Preclinical | US | 01 Mar 2023 | |
Non-Small Cell Lung Cancer | Preclinical | JP | 01 Mar 2023 |